Clinical News and Research

RSS

Powering the Biotechnology Revolution through Cloud R&D

In this interview, we speak to Sajith Wickramasekara, CEO and Co-Founder of Benchling, about cloud R&D and how it is powering the biotechnology revolution.

From Benchling 10 Dec 2021

New classification method divides breast cancers into 12 distinct biological groups

Researchers at UNC Lineberger Comprehensive Cancer Center have taken a major step forward in melding two key methods for studying breast cancer: one by genetic analysis and the second by looking at the architecture of cells, or their pathology.

9 Dec 2021

ASHG launches major initiative to understand, document experiences of past injustice in human genetics research

The American Society of Human Genetics today announced a major year-long initiative to understand and document experiences of past injustice, as well as progress toward justice, in the human genetics research field and the Society.

9 Dec 2021

Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

A next-generation technology that allows the study of protein expression at the single-cell level and the location of the cells within the tumor microenvironment (TME) was feasible and provided information on the benefit of adding the immune checkpoint inhibitor atezolizumab (Tecentriq) to chemotherapy as neoadjuvant treatment for patients with early high-risk and locally advanced triple negative breast cancer (TNBC), according to results presented at the San Antonio Breast Cancer Symposium, held December 7-10, 2021.

8 Dec 2021

World's first metal-organic framework antibody-drug delivery system developed

It sounds like the stuff of science fiction: a man-made crystal that can be attached to antibodies and then supercharge them with potent drugs or imaging agents that can seek out diseased cells with the highest precision, resulting in fewer adverse effects for the patient.

8 Dec 2021

New strategy to improve the therapeutic efficacy of liver cancer immunotherapy

In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach.

8 Dec 2021

Researchers identify protein that promotes wound healing and repair

Recent research discovered a protein known as Agrin that is known to promote wound healing and repair when induced after the injury of skin tissue.

8 Dec 2021

Lunaphore to host inaugural Spatial Biology Week™ virtual meeting

Lunaphore today announced the events and activities planned around the inaugural Lunaphore Spatial Biology Week™, taking place virtually December 6-10, 2021.

From Lunaphore 7 Dec 2021

Cancer drug effective against Alzheimer’s disease, says research

According to recent research carried out by researchers from the Weill Cornell Medicine, a gene mutation associated with Alzheimer’s disease changes a signaling pathway in specific immune cells of individuals with the disease.

7 Dec 2021

New nanoparticle adjuvant could lead to more powerful vaccines

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant -; a compound that stimulates the immune system to produce a stronger response.

6 Dec 2021

Integration of digital and molecular data could enable individualized prevention of disease

Analyzing molecular characteristics and their variation during lifestyle changes, by combining digital tools, classical laboratory tests and new biomolecular measurements, could enable individualised prevention of disease.

3 Dec 2021

Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient

Leading Producer of Controlled Substance APIs Now Supplying Lisdex API to Generic Drug Manufacturers Preparing for the 2023 Patent Expiry of Top-Selling Branded ADHD Therapy

3 Dec 2021

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.

2 Dec 2021

Clinical News and Research

Powering the Biotechnology Revolution through Cloud R&D

New classification method divides breast cancers into 12 distinct biological groups

ASHG launches major initiative to understand, document experiences of past injustice in human genetics research

Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

World's first metal-organic framework antibody-drug delivery system developed

New strategy to improve the therapeutic efficacy of liver cancer immunotherapy

Researchers identify protein that promotes wound healing and repair

Lunaphore to host inaugural Spatial Biology Week™ virtual meeting

Cancer drug effective against Alzheimer’s disease, says research

New nanoparticle adjuvant could lead to more powerful vaccines

Integration of digital and molecular data could enable individualized prevention of disease

Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Study identifies genes that protect ovarian cancer from antitumor immunity

New CRISPR technology could improve diagnostic tests for COVID-19

Synthetic food additive causes detrimental effects on the gut microbiota

Lung cancer: Cholesterol metabolism of tumor-associated macrophages found to be severely compromised

Custom Biofluid & Tissue Procurement Service

Introducing the PhysioMimix™ OOC Multi-Organ Microphysiological System

Treatment with common allergy medication linked to improved immunotherapy response

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics